Submission Of Copies Of Newspaper Advertisements
In continuation of our letter dated May 2, 2018, we enclose copies of the advertisements published on May 3, 2018, in MINT (English) and HINDUSTAN (Hindi) with respect to notice of the Board Meeting scheduled to be held on May 9, 2018. This is for information and record. Schedule Of Investor Conference Call For Jubilant Life Sciences Limited - Audited Financial Results For The Year Ended March 31, 2018
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on May 9, 2018 after submission of the financial results for the year ended March 31, 2018 to the Stock Exchanges. The details of Conference Call are attached. This is for information and record. Board to consider FY18 results & Dividend on May 09, 2018
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 09, 2018, to inter-alia consider:1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2018;2. Recommendation of Dividend for the Financial Year ended March 31, 2018. Intimation Of Board Meeting - May 9, 2018
1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2018; 2. Recommendation of Dividend for the Financial Year ended March 31, 2018. Update
We refer to our letter dated February 1, 2018 intimating about the SEBI Adjudication Order dated January 31, 2018 (the 'SEBI Adjudication Order') imposing a penalty of Rs. 10 Lac each on Jubilant Life Sciences Limited, Jubilant Stock Holding Private Limited, Mr. Shyam Sunder Bhartia and Mr. Hari Shanker Bhartia (collectively referred to as the 'Parties').... Issuance Of Commercial Papers Of Rs. 75 Crore
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has issued Commercial Papers ('CPs') of Rs. 75 crore on April 23, 2018 as per the attached letter. Shareholding for the Period Ended March 31, 2018
Jubilant Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here Certificate Obtained From A Practising Company Secretary Under Regulation 40(9) And Regulation 40(10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
We have examined the relevant books and records of Jubilant Life Sciences Limited, having its Registered Office at Bhartiagram, Gajraula, District Amroha- 244 223, Uttar Pradesh produced before us by their Registrar and Share Transfer Agent, Alankit Assignments Limited for the purpose of issuing a certificate under Regulation 40(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and based... Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- Rajiv ShahDesignation :- Company Secretary and Compliance Officer Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we certify the following: 1. M/s Alankit Assignments Limited, a Category-I Registrar and Share Transfer Agent, registered with the Securities and Exchange Board of India vide Registration No.: INR000002532, is the Registrar and Share Transfer Agent (the 'RTA') of Jubilant Life Sciences Limited....